About 46,958 results

U.S. set to sue Google, to be joined by about eight states -- sources

Jan 24th, 2023 - WASHINGTON, Jan 24 (Reuters) - The U.S. Justice Department will be joined by about eight states in an antitrust lawsuit against Alphabet’s Google, which is expected to be filed this week, according to two sources familiar with the matter. The lawsuit is expected to allege the Big Tech company broke antitrust rules with the way it runs its digital advertising business. (Reporting by Diane Bartz)

Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms

Jan 24th, 2023 - (Reuters) -Eli Lilly and Co plans to invest an additional $450 million to expand capacity of a plant in North Carolina, the U.S. drugmaker said on Tuesday, as it races to boost production ahead of a decision on its promising obesity treatment. The company has been struggling to meet strong demand for its incretin products, which include its blockbuster diabetes drug Trulicity and recently launc...

Health Rounds: New test detects deadly lung cancer earlier

Jan 24th, 2023 - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Jan 24 (Reuters) - Hello Health Rounds Readers! Today we look at early-stage research that suggests we may soon be able to detect a deadly form of lung cancer before it spreads and becomes incurable, while it might also be po...

US STOCKS-Wall St set to open lower as earnings roll in, chipmakers retreat

Jan 24th, 2023 - (For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) 3M slides as profit falls on charges, weakening demand J&J falls on sales growth warning; GE up on Q4 earnings beat AMD leads fall in chipmakers after big gains on Monday Futures down: Dow 0.27%, S&P 0.29%, Nasdaq 0.40% (Updates prices, details; adds comment) By Shreyashi Sanyal and Johann M ...

Eli Lilly to invest $450 mln to expand diabetes drug plant capacity

Jan 24th, 2023 - Jan 24 (Reuters) - Eli Lilly and Co said on Tuesday it plans to invest an additional $450 million to expand its manufacturing capacity at the Research Triangle Park facility in North Carolina to support increased demand for its diabetes drugs. Since 2020, the drugmaker has committed around $4 billion to new manufacturing facilities in North Carolina, including $1.7 billion for the development a...

J&J quarterly profit beats on pharmaceuticals strength

Jan 24th, 2023 - Jan 24 (Reuters) - Johnson & Johnson beat estimates for fourth-quarter profit on Tuesday as increased sales of pharmaceutical products helped it weather a hit from a stronger dollar Excluding items, J&J earned $2.35 per share, above analysts’ average estimates of $2.23 per share, according to IBES data from Refinitiv. (Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Anil D’...

Health Rounds: AI speeds MRI exams

Jan 19th, 2023 - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Jan 19 - Hello Health Rounds Readers! Today we report on two studies of potential applications for artificial intelligence in medicine: MRI scanning, and smart watch identification of heart rhythm problems. We also share earl...

Rogers, Shaw say merger 'must be allowed to proceed'

Jan 17th, 2023 - TORONTO, Jan 17 (Reuters) - Rogers Communications Inc’s C$20 billion ($14.9 billion) acquisition of rival Shaw Communications Inc has been delayed long enough and must be allowed to proceed despite the competition bureau’s opposition, the companies said in a legal filing on Tuesday. The companies face off against the Competition Bureau, which is arguing against the deal that would create Canada...

Health Rounds: U.S. lags in adoption of improved heart attack test

Jan 17th, 2023 - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Jan 17 - Hello Health Rounds Readers! Highly sensitive blood tests for confirming a heart attack are widely employed around the world, but a new study suggests most U.S. hospitals still do not use them. Data from this study m...

CANADA STOCKS-TSX hits one-month high as domestic inflation eases

Jan 17th, 2023 - (Adds comments, details; updates prices) Barrick Gold reports highest quarterly gold output Bombardier rises to 3-1/2 year high on forecast raise Domestic inflation fell to annual rate of 6.3% By Shristi Achar A and Johann M Cherian Jan 17 (Reuters) - Canada’s main stock index rose on Tuesday, eying gains for the eighth straight session after data showed that domestic inflation eased in Decembe...

British regulator launches probe into Asda's purchase of petrol forecourt estate

Jan 17th, 2023 - Jan 17 (Reuters) - Britain’s competition regulator said on Tuesday it has begun a phase 1 probe into British supermarket group Asda Stores’ purchase of Co-Operative Group’s petrol forecourt estate. (Reporting by Muhammed Husain in Bengaluru; Editing by Shailesh Kuber)

UPDATE 1-China approves 88 games in January, including titles by Tencent and NetEase

Jan 17th, 2023 - (Adds details) BEIJING, Jan 17 (Reuters) - China’s video games regulator on Tuesday granted publishing licences to 88 online games, including titles belonging to Tencent Holdings Ltd , NetEase Inc and miHoYo. Shenzhen-based Tencent, the world’s largest gaming company, received at least one game licence for a mobile game named “Yuanmengzhixing”, the list published by the National Press and Publi...

Didi's China ride-hailing app back on some app stores

Jan 17th, 2023 - BEIJING, Jan 17 (Reuters) - Chinese technology company Didi Global’s domestic ride-hailing app returned to some Android app stores on Tuesday, according to Reuters checks and a source with direct knowledge of the matter. Didi has been awaiting approval to resume new user registrations and downloads of its 25 banned apps in China as a key step to return to normal business since its regulatory tr...

China defends its retaliation against South Korea, Japan COVID curbs

Jan 11th, 2023 - BEIJING (Reuters) -Chinese state media defended on Wednesday the retaliatory measures against South Korea and Japan over their COVID-19 travel curbs as “reasonable”, while Chinese tourists decried Seoul’s “insulting” treatment on social media. China re-opened its borders on Sunday after three years of isolation under the world’s strictest regime of COVID restrictions, which Beijing abruptly beg...

EXCLUSIVE-Google warns Android growth in India will stall due to antitrust order

Jan 10th, 2023 - NEW DELHI, Jan 10 (Reuters) - The growth of Google’s Android ecosystem is on the brink of stalling in India due to an antitrust order that asks the company to change how it markets the platform, the U.S. company has said in a Supreme Court challenge seen by Reuters. The Competition Commission of India (CCI) in October fined Alphabet Inc-owned Google $161 million for exploiting its dominant posi...

Abbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025

Jan 10th, 2023 - (Reuters) -AbbVie Inc on Tuesday raised its 2025 sales forecast of its newer immunology drugs Skyrizi and Rinvoq to more than $17.5 billion as it hopes to replace the loss of revenue from its blockbuster rheumatoid arthritis drug Humira. The company’s previous sales outlook for Skyrizi and Rinvoq in 2025 was more than $15 billion. AbbVie also expects peak sales of the drugs to exceed $21 billio...

Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand

Jan 10th, 2023 - HONG KONG (Reuters) - China’s Shenzhen Kangtai Biological Products reported a net loss in 2022, hurt by waning demand for COVID-19 vaccine shots. The decline from a net profit of 1.3 billion yuan ($191.71 million) in 2021 to net losses of up to 150 million yuan was mainly driven by weaker COVID vaccine demand, it said in a filing to the Shenzhen stock exchange. ($1 = 6.7810 Chinese yuan renminbi)

Abbvie expects sales of two drugs to exceed $21 bln in 2027

Jan 10th, 2023 - Jan 10 (Reuters) - AbbVie said on Tuesday it expects combined peak sales of plaque psoriasis drug Skyrizi and anti-inflammatory medicine Rinvoq to exceed $21 billion in 2027. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)

Spain seeks to set nuclear and hydro prices to end windfall profits

Jan 10th, 2023 - MADRID, Jan 10 (Reuters) - Spain wants the EU to allow it to set prices for nuclear and hydroelectric as it seeks to decouple the cost of electricity production from gas and curb windfall profits, Energy Ministry sources said. The reform of the energy market proposed by Spain seeks to prevent these sources of energy with lower production costs from benefiting from the high prices of other resou...

CORRECTED-BioNTech to acquire British artificial intelligence startup InstaDeep

Jan 10th, 2023 - (Corrects currency to pounds (not euros)) Jan 10 (Reuters) - BioNTech SE said on Tuesday it will acquire the rest of British artificial intelligence startup InstaDeep that it does not already own for a total upfront consideration of about 362 million pounds ($439 million) in cash and stock. ($1 = 0.9325 euros) ($1 = 0.8243 pounds) (Reporting by Pratik Jain; Editing by Shinjini Ganguli)